Global Regulatory T-Cell Research from 2000 to 2015: A Bibliometric Analysis
- PMID: 27611317
- PMCID: PMC5017768
- DOI: 10.1371/journal.pone.0162099
Global Regulatory T-Cell Research from 2000 to 2015: A Bibliometric Analysis
Erratum in
-
Correction: Global Regulatory T-Cell Research from 2000 to 2015: A Bibliometric Analysis.PLoS One. 2017 Jan 23;12(1):e0170850. doi: 10.1371/journal.pone.0170850. eCollection 2017. PLoS One. 2017. PMID: 28114400 Free PMC article.
Abstract
We aimed to analyze the global scientific output of regulatory T-cell (Treg) research and built a model to qualitatively and quantitatively evaluate publications from 2000 to 2015. Data were obtained from the Web of Science Core Collection (WoSCC) of Thomson Reuters on January 1, 2016. The bibliometric method and Citespace III were used to analyze authors, journals, publication outputs, institutions, countries, research areas, research hotspots, and trends. In total, we identified 35,741 publications on Treg research from 2000 to 2015, and observed that the annual publication rate increased with time. The Journal of Immunology published the highest number of articles, the leading country was the USA, and the leading institute was Harvard University. Sakaguchi, Hori, Fontenot, and Wang were the top authors in Treg research. Immunology accounted for the highest number of publications, followed by oncology, experimental medicine, cell biology, and hematology. Keyword analysis indicated that autoimmunity, inflammation, cytokine, gene expression, foxp3, and immunotherapy were the research hotspots, whereas autoimmune inflammation, gene therapy, granzyme B, RORγt, and th17 were the frontiers of Treg research. This bibliometric analysis revealed that Treg-related studies are still research hotspots, and that Treg-related clinical therapies are the research frontiers; however, further study and collaborations are needed worldwide. Overall, our findings provide valuable information for the editors of immunology journals to identify new perspectives and shape future research directions.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures










References
-
- Sakaguchi S. S N, Asano M., Itoh M., Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. 1995;155(3):1151–64. . - PubMed
-
- Montane J. O M, Alvarez S., Bischoff L., Dai D. L., Soukhatcheva G., Priatel J. J., Hardenberg G., Levings M. K., Tan R., Orban P. C., Verchere C. B. CCL22 Prevents Rejection of Mouse Islet Allografts and Induces Donor-Specific Tolerance. Cell Transplant. 2015;24(10):2143–54. 10.3727/096368914X685249 . - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources